These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2413558)

  • 21. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
    Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
    Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation.
    Giulianelli R; Pecoraro S; Sepe G; Leonardi R; Gentile BC; Albanesi L; Brunori S; Mavilla L; Pisanti F; Giannella R; Morello P; Tuzzolo D; Coscione M; Galasso F; D'Angelo T; Ferravante P; Morelli E; Miragliuolo A;
    Arch Ital Urol Androl; 2012 Jun; 84(2):94-8. PubMed ID: 22908779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Our experience with a hexane extract of Serenoa repens in the treatment of benign prostatic hypertrophy].
    Ollé Carreras J
    Arch Esp Urol; 1987 Jun; 40(5):310-3. PubMed ID: 2444169
    [No Abstract]   [Full Text] [Related]  

  • 24. [The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia].
    Aliaev IuG; Vinarov AZ; Demidko IuL; Spivak LG
    Urologiia; 2013; (4):32-6. PubMed ID: 24159762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comment on the appropriateness of The Prostate publishing a trial comparing Permixon to finasteride without a placebo control group.
    Gillenwater JY
    Prostate; 1998 Nov; 37(3):194. PubMed ID: 9792137
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficacy of a combined Sabal-urtica preparation in the symptomatic treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study].
    Popa G; Hägele-Kaddour H; Walther C
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():103-8. PubMed ID: 16261945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
    Coulson S; Rao A; Beck SL; Steels E; Gramotnev H; Vitetta L
    Complement Ther Med; 2013 Jun; 21(3):172-9. PubMed ID: 23642948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients.
    Di Silverio F; D'Eramo G; Lubrano C; Flammia GP; Sciarra A; Palma E; Caponera M; Sciarra F
    Eur Urol; 1992; 21(4):309-14. PubMed ID: 1281103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serenoa repens--the saw palmetto or dwarf palm].
    Swoboda H; Kopp B
    Wien Med Wochenschr; 1999; 149(8-10):235. PubMed ID: 10483689
    [No Abstract]   [Full Text] [Related]  

  • 30. Serenoa repens treatment modifies bax/bcl-2 index expression and caspase-3 activity in prostatic tissue from patients with benign prostatic hyperplasia.
    Vela-Navarrete R; Escribano-Burgos M; Farré AL; García-Cardoso J; Manzarbeitia F; Carrasco C
    J Urol; 2005 Feb; 173(2):507-10. PubMed ID: 15643230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
    Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP
    Eur Urol; 2002 May; 41(5):497-506; discussion 506-7. PubMed ID: 12074791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].
    Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP;
    Prog Urol; 2002 Jun; 12(3):384-92; discussion 394-4. PubMed ID: 12189744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serenoa repens.
    Altern Med Rev; 1998 Jun; 3(3):227-9. PubMed ID: 9630741
    [No Abstract]   [Full Text] [Related]  

  • 34. Benign prostatic hyperplasia treated with saw palmetto: a literature search and an experimental case study.
    McPartland JM; Pruitt PL
    J Am Osteopath Assoc; 2000 Feb; 100(2):89-96. PubMed ID: 10732392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Saw palmetto. Serenoa repens. Also known as Serenoa serrulata, Sabal serrulata and the dwarf palm.
    Barnes J
    J Prim Health Care; 2009 Dec; 1(4):323. PubMed ID: 20690343
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia.
    Sinescu I; Geavlete P; Multescu R; Gangu C; Miclea F; Coman I; Ioiart I; Ambert V; Constantin T; Petrut B; Feciche B
    Urol Int; 2011; 86(3):284-9. PubMed ID: 21304222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients--PERMAL study subset analysis].
    Debruyne F; Boyle P; Calais da Silva F; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP; Schulman C
    Prog Urol; 2004 Jun; 14(3):326-31. PubMed ID: 15373174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis.
    Debruyne F; Boyle P; Calais Da Silva F; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP; Schulman CC
    Eur Urol; 2004 Jun; 45(6):773-9; disucssion 779-80. PubMed ID: 15149751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH.
    Lowe FC; Dreikorn K; Borkowski A; Braeckman J; Denis L; Ferrari P; Gerber G; Levin R; Perrin P; Senge T
    Prostate; 1998 Nov; 37(3):187-93. PubMed ID: 9792136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of a flaxseed hull extract in the symptomatic management of benign prostatic hyperplasia: a parallel, randomized, double-blind, placebo-controlled, pilot study.
    Simons R; Sonawane N; Verbruggen M; Chaudhary J
    J Med Food; 2015 Feb; 18(2):233-40. PubMed ID: 25546379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.